StockData
Compugen Ltd logo

Compugen Ltd (CGEN) income statement

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
87.3%
Operating margin
43.1%
Net margin
48.6%
Return on equity, FY2025
44.8%

Financial strength

Current ratio
5.72
Debt to equity
–
Debt to assets
–
Cash to current liabilities
45.4%

Valuation

P/E ratio
5.2
Price to sales
2.55
Price to book
2.09
Dividend yield
–

See a number that looks wrong?